MedTrace Logo

The Expression of ZEB1 in CTCs Associated With Metastasis and Recurrence for Gastric Cancer

NCT02431078 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2015-07-29

No results posted yet for this study

Summary

The aim of this study was to investigate the expression of ZEB1 in CTCs for gastric cancer, its correlation with the clinicopathology of gastric cancer, and the role of ZEB1 in invasion and metastasis in gastric cancer.

Conditions

  • Stomach Neoplasms

Interventions

PROCEDURE

Routine comprehensive treatment

Radical gastrectomy for gastric cancer and postoperative adjuvant chemotherapy

Sponsors & Collaborators

  • wei bo

    lead OTHER

Principal Investigators

  • Wei bo, MD · Vice director of the general surgery department, Chinese PLA General Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2018-06-30
Completion
2018-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02431078 on ClinicalTrials.gov